News About: Pharm. Industry
Dong-A wins Taxotele patent suit against Sanofi-Aventis
French drug maker Sanofi-Aventis SA lost a patent lawsuit against Dong-A Pharmaceutical over its treatment for colorectal cancer, Taxotele (docetaxel) that is marketed in more than 100 countries to treat lung, prostat...
Zuellig Pharma to distribute L’oreal products to pharmacy
Zuellig Pharma Korea said recently it has signed an agreement with L’oreal Korea to supply the latter’s three flagship products to pharmacy market – hair dye, UV-screening agent and lipcare.
“We will provide pharma...
Drug pricing reform corners Korean drugmakers
A new wave of price cuts for drugs is speculated to be imminent, which has stirred up concerns among drug makers, domestic and multinational alike.
Domestic drug makers are concerned by the potentially significant ...
Daewoong and AstraZeneca Korea to co-market Symbicort in Korea
Daewoong Pharmaceutical and AstraZeneca Korea (AZK) Monday announced that the two companies have signed an agreement to co-market Symbicort (budesonide/formoterol) in Korea, in addition to Nexium.
Launched in 2001,...
Dong-A to develop molecular diagnostic technology
Dong-A Pharmaceutical and the US-based Nanogea announced on July 22 that both companies have signed a letter of intent for the co-development and commercialization of new molecular diagnostics, using the latter’s prop...
KPMA proposes meeting with President
The Korea Pharmaceutical Manufacturers Association (KPMA) Friday proposed a meeting with President Lee Myung-bak.
“Having talks with President Lee is quite meaningful as we want to discuss the unclear growth of the...
Dong-A to discontinue TV ads on Bacchus-D
Dong-A Pharmaceutical, the nation's No.1 drug maker, will discontinue its television advertisement on the popular Bacchus-D energy drink sooner or later.
As 48 over-the-counter (OTC) medicines, including Bacchus-D,...
Government seeking to expand RFID system for pharmaceuticals
Radio tags area likely to be expanded on the containers of 50 percent of all drugs sold here by 2015, the government said recently, in order to create a wireless tracking system that enables better inventory control a...
Green Cross R&D center to open by 2013
Green Cross Corp. broke ground Thursday to build a major global research & development (R&D) center in the Yongin Mokam Town of Kyunggi Province, the largest of its kind in the metropolitan region.
The 28,510-squar...
Government urged to reconsider drug price cut
To further stimulate research and development (R&D) in the pharmaceutical industry, the government should enhance certainty in pricing and reimbursement and adequately reward the developers of drugs with proven clinic...
